Left Atrial Myxoma Causing Mitral Valve Obstruction with Right Ventricular Dysfunction Complicated by Atrial Fibrillation
Kamal Kajal, Krishna P Gourav, Imran Bhat, Srinath Damodaran
Atrial fibrillation, Left atrium myxoma, Right ventricular dysfunction
Citation Information :
Kajal K, Gourav KP, Bhat I, Damodaran S. Left Atrial Myxoma Causing Mitral Valve Obstruction with Right Ventricular Dysfunction Complicated by Atrial Fibrillation. J Perioper Echocardiogr 2019; 7 (1):12-14.
Myxomas are the most common type of tumors of the heart and account for 83% of the primary tumors. The left atrium (LA) is the most common site for myxoma, followed by the right atrium. Obstructive symptoms of myxomas can mimic as mitral stenosis, and the severity increases due to an increase in heart rate such as the development of atrial fibrillation (AF). There is a high probability of developing pulmonary artery hypertension and right ventricular (RV) failure in patients with long-standing LA myxomas which can further be complicated by the development of AF. As the majority of patients with LA myxomas present late due to their nonspecific symptoms, a thorough assessment of pulmonary artery hypertension and RV function assessment should be done before surgical intervention.
Ullah W, Mcgovern R. Natural history of an atrial myxoma. Age Ageing 2005;34(2):186–188. DOI: 10.1093/ageing/afi010.
Reynen K. Cardiac myxomas. New Engl J Med 1995;333(24):1610–1617. DOI: 10.1056/NEJM199512143332407.
Bou E, Hernández P, Cerezo L, et al. Heart tumors in Puerto Rico de novo atrial fibrillation as clinical presentation in a subgroup of patients. P R Health Sci J 2013;32(1):14–17.
Blondeau P. Primary cardiac tumors--French studies of 533 cases. Thorac Cardiovasc Surg 1990;38(Suppl 2):192–195. DOI: 10.1055/s-2007-1014065.
Kuon E, Kreplin M, Weiss W, et al. The challenge presented by right atrial myxoma. Herz 2004;29(7):702–709. DOI: 10.1007/s00059-004-2571-7.
Goswami KC, Shrivastava S, Bahl VK, et al. Cardiac myxomas: clinical and echocardiographic profile. Int J Cardiol 1998;63(3):251–259. DOI: 10.1016/S0167-5273(97)00316-1.
Cere E, Lombardi A, Vinelli S, et al. Concomitant left atrial myxoma and atrial fibrillation in patients with peripheral embolism. Ital Heart J Suppl 2002;3(2):232–234.
Koo SH, Cha TJ, Choi YJ, et al. Evidence for a role of inflammation in atrial fibrillation associated with heart failure and the protective effects of angiotensin receptor blockade. Heart Rhythm 2008;5:S263.
Pucci A, Gagliardotto P, Zanini C, et al. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000;140(1):134–138. DOI: 10.1067/mhj.2000.107176.
Keeling IM, Oberwalder P, Anelli-Monti M, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002;22(6):971–977. DOI: 10.1016/S1010-7940(02)00592-4.
Oliveira R, Branco L, Galrinho A, et al. Cardiac myxoma: a 13-year experience in echocardiographic diagnosis. Rev Port Cardiol 2010;29(7–8):1087–1100.
Nakano T, Mayumi H, Hisahara M, et al. The relationship between functional class, pulmonary artery pressure and size in left atrial myxoma. Cardiovasc Surg 1996;4(3):320–323. DOI: 10.1016/0967-2109(95)00090-9.
Rottlaender D, Motloch LJ, Schmidt D, et al. Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS One 2012;7(3):e33902. DOI: 10.1371/journal.pone.0033902.
Kim B-K, Cho J-N, Park H-J, et al. Reversible pulmonary hypertension in adolescent with left atrial myxoma. J Cardiovasc Ultrasound 2011;19(4):221–223. DOI: 10.4250/jcu.2011.19.4.221.